Pathogenic Sells 100,000 Copies in 1 Week as 2-Person Studio Hits 5,800 Peak Players
Updated
Updated · Tech Times · Jul 27
Pathogenic Sells 100,000 Copies in 1 Week as 2-Person Studio Hits 5,800 Peak Players
2 articles · Updated · Tech Times · Jul 27
Summary
100,000 copies sold and more than 5,800 concurrent players in Pathogenic’s first Steam week marked a breakout launch for Aberrant Labs’ two-person team.
Pathogenic’s hook puts players in control of a parasite inside a human host, and its organelle-grafting system turns upgrades into physical body-building rather than abstract stat boosts.
97% positive reviews across 1,219 ratings point to that design resonating, with players highlighting build variety, biological theme and the soundtrack.
A 20% launch discount cuts the price to $7.99 through July 30, while three patches in the first 10 days — including balance fixes and 40 new rooms — signal active post-launch support.
PC Gamer framed the game as a strong answer to Spore’s abandoned cell-stage potential, helping explain why it broke through in a crowded roguelite market.